[HTML][HTML] Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines

L Guo, S Lin, Z Chen, Y Cao, B He, G Lu - Signal Transduction and …, 2023 - nature.com
The ongoing global pandemic of coronavirus disease 2019 (COVID-19), caused by severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused devastating impacts …

[HTML][HTML] 1, 2-Dibenzoylhydrazine as a multi-inhibitor compound: A morphological and docking study

V Patamia, G Floresta, C Zagni, V Pistarà… - International Journal of …, 2023 - mdpi.com
In the framework of the multitarget inhibitor study, we report an in silico analysis of 1, 2-
dibenzoylhydrazine (DBH) with respect to three essential receptors such as the ecdysone …

[HTML][HTML] Heparan sulfate and enoxaparin interact at the interface of the spike protein of HCoV-229E but not with HCoV-OC43

V Fuochi, G Floresta, R Emma, V Patamia, M Caruso… - Viruses, 2023 - mdpi.com
It is known that the spike protein of human coronaviruses can bind to a secondary receptor,
or coreceptor, to facilitate the virus entry. While HCoV-229E uses human aminopeptidase N …

[HTML][HTML] Identification of potential lead compounds targeting novel druggable cavity of SARS-CoV-2 spike trimer by molecular dynamics simulations

Y Zhao, Y Zhao, L Xie, Q Li, Y Zhang, Y Zang… - International Journal of …, 2023 - mdpi.com
The global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has become an urgent public health problem. Spike (S) protein mediates the fusion between …

[HTML][HTML] Mapping IgA Epitope and Cross-Reactivity between Severe Acute Respiratory Syndrome-Associated Coronavirus 2 and DENV

SG De-Simone, P Napoleão-Pêgo, GC Lechuga… - Vaccines, 2023 - mdpi.com
Background: The newly introduced COVID-19 vaccines have reduced disease severity and
hospitalizations. However, they do not significantly prevent infection or transmission. In the …

[HTML][HTML] How can artificial intelligence be utilized for de novo drug design against COVID-19 (SARS-CoV-2)?

G Floresta, C Zagni, V Patamia… - Expert Opinion on Drug …, 2023 - Taylor & Francis
The COVID-19 virus was first identified in Wuhan, China, in December 2019. On 11 March
2020, the World Health Organization declared the COVID-19 virus to be a pandemic. It …

[HTML][HTML] Steered Molecular Dynamics Simulations Study on FABP4 Inhibitors

R Tomarchio, V Patamia, C Zagni, L Crocetti… - Molecules, 2023 - mdpi.com
Ordinary small molecule de novo drug design is time-consuming and expensive. Recently,
computational tools were employed and proved their efficacy in accelerating the overall drug …

Selective noncovalent proteasome inhibiting activity of trifluoromethyl‐containing gem‐quaternary aziridines

L Ielo, V Patamia, A Citarella… - Archiv der …, 2023 - Wiley Online Library
The ubiquitin‐proteasome pathway (UPP) represents the principal proteolytic apparatus in
the cytosol and nucleus of all eukaryotic cells. Nowadays, proteasome inhibitors (PIs) are …

Design, synthesis, in vitro evaluation, and molecular modeling studies of N‐substituted benzomorphans, analogs of LP2, as novel MOR ligands

G Costanzo, V Patamia, R Turnaturi… - Chemical Biology & …, 2023 - Wiley Online Library
Benzomorphans have been investigated in medicinal chemistry for developing new drugs.
This nucleus could be considered a versatile scaffold. The physicochemical properties of …

γ‐Cyclodextrins as Supramolecular Reactors for the Three‐component Aza‐Darzens Reaction in Water

V Patamia, E Saccullo, C Zagni… - … A European Journal, 2024 - Wiley Online Library
In recent decades, many efforts have been devoted to studying reactions catalyzed in
nanoconfined spaces. The most impressive aspect of catalysis in nanoconfined spaces is …